Scientists believe they have made a radical breakthrough in the treatment of cholesterol using advanced gene-silencing. It is hoped new drugs will offer an alternative for the one in five people who are resistant to traditional cholesterol medicine.
A new drug could have a radical effect on lowering "bad" cholesterol using advanced gene-silencing, scientists have said.
Research published in The Lancet medical journal showed one dose of the experimental drug cut levels of the "bad" form of cholesterol in healthy volunteers by up to 57%.
Scientists believe the drug, known as ALN-PCS, could provide an alternative treatment for patients with high cholesterol who do not respond well to conventional statins.
More than 5 million people in the UK currently take statins to reduce their risk of heart disease. However, one in five people are resistant to them.
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.